Takeda Pharmaceutical Company Limited American Depositary Share — Quarterly Financial Statistics (NYSE:TAK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

News

Takeda Pharmaceutical: The Downside Was Forecastable (NYSE:TAK)

Takeda Designed A Psoriasis Pill Using AI. It Just Walloped Bristol's Sotyktu In A Head-To-Head Test.

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Takeda Pharmaceutical Company Limited (TAK) Q4 FY2025 Earnings Call Transcript

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

Takeda's Rich Pipeline Optionality Is Worth A 'Buy' (NYSE:TAK)

Takeda Pharmaceutical Company Limited (TAK) Q4 2026 Earnings Call Transcript

DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects

Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?